The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lister, P. D., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,789
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
Livermore, D. M. (2002) · Clinical Infectious Diseases · doi:10.1086/338782 · Cited by 1,453
Hentzer, M., Riedel, K., Rasmussen, T. B., Heydorn, A., Andersen, J. B., Parsek, M. R., Rice, S. A., Eberl, L., Molin, S., Høiby, N., et al. (2002) · Microbiology · doi:10.1099/00221287-148-1-87 · Cited by 1,050
Phage treatment of human infections
Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011) · Bacteriophage · doi:10.4161/bact.1.2.15845 · Cited by 980
The type III secretion system of Pseudomonas aeruginosa: infection by injection
Hauser, A. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2199 · Cited by 968
Saiman, L., Marshall, B. C., Mayer-Hamblett, N., Burns, J. L., Quittner, A. L., Cibene, D. A., Coquillette, S., Fieberg, A. Y., Accurso, F. J., Campbell III, P. W., et al. (2003) · JAMA · doi:10.1001/jama.290.13.1749 · Cited by 958
Wright, A., Hawkins, C. H., Änggård, E. E., & Harper, D. R. (2009) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2009.01973.x · Cited by 864
Iron and Pseudomonas aeruginosa biofilm formation
Banin, E., Vasil, M. L., & Greenberg, E. P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504266102 · Cited by 801
Pathogen–Host Interactions in Pseudomonas aeruginosa Pneumonia
Sadikot, R. T., Blackwell, T. S., Christman, J. W., & Prince, A. S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1044so · Cited by 799
Cell-to-Cell Signaling and Pseudomonas aeruginosa Infections
Van Delden, C., & Iglewski, B. H. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0404.980405 · Cited by 745
A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation
O’Loughlin, C. T., Miller, L. C., Siryaporn, A., Drescher, K., Semmelhack, M. F., & Bassler, B. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316981110 · Cited by 744
The Multiple Signaling Systems Regulating Virulence in Pseudomonas aeruginosa
Nadal Jimenez, P., Koch, G., Thompson, J. A., Xavier, K. B., Cool, R. H., & Quax, W. J. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05007-11 · Cited by 736
Poole, K., Krebes, K., McNally, C., & Neshat, S. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.22.7363-7372.1993 · Cited by 688
Kaneko, Y., Thoendel, M., Olakanmi, O., Britigan, B. E., & Singh, P. K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30783 · Cited by 661
Principles of assessing bacterial susceptibility to antibiotics using the agar diffusion method
Bonev, B., Hooper, J., & Parisot, J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn090 · Cited by 644
Déziel, E., Lépine, F., Milot, S., He, J., Mindrinos, M. N., Tompkins, R. G., & Rahme, L. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307694100 · Cited by 637
Manefield, M., de Nys, R., Naresh, K., Roger, R., Givskov, M., Peter, S., & Kjelleberg, S. (1999) · Microbiology · doi:10.1099/13500872-145-2-283 · Cited by 625
Screening for Quorum-Sensing Inhibitors (QSI) by Use of a Novel Genetic System, the QSI Selector
Rasmussen, T. B., Bjarnsholt, T., Skindersoe, M. E., Hentzer, M., Kristoffersen, P., Köte, M., Nielsen, J., Eberl, L., & Givskov, M. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.5.1799-1814.2005 · Cited by 622
Halogenated furanones inhibit quorum sensing through accelerated LuxR turnover
Manefield, M., Rasmussen, T. B., Henzter, M., Andersen, J. B., Steinberg, P., Kjelleberg, S., & Givskov, M. (2002) · Microbiology · doi:10.1099/00221287-148-4-1119 · Cited by 604
Quinolones: from antibiotics to autoinducers
Heeb, S., Fletcher, M. P., Chhabra, S. R., Diggle, S. P., Williams, P., & Cámara, M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2010.00247.x · Cited by 595
Teplitski, M., Robinson, J. B., & Bauer, W. D. (2000) · Molecular Plant-Microbe Interactions® · doi:10.1094/mpmi.2000.13.6.637 · Cited by 591
Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa
Srinivas, N., Jetter, P., Ueberbacher, B. J., Werneburg, M., Zerbe, K., Steinmann, J., Van der Meijden, B., Bernardini, F., Lederer, A., Dias, R. L. A., et al. (2010) · Science · doi:10.1126/science.1182749 · Cited by 554
Guilhelmelli, F., Vilela, N., Albuquerque, P., Derengowski, L. D. S., Silva-Pereira, I., & Kyaw, C. M. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00353 · Cited by 546
Leid, J. G., Willson, C. J., Shirtliff, M. E., Hassett, D. J., Parsek, M. R., & Jeffers, A. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7512 · Cited by 525
Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense
Geiszt, M., Witta, J., Baff, J., Lekstrom, K., & Leto, T. L. (2003) · The FASEB Journal · doi:10.1096/fj.02-1104fje · Cited by 504
Diggle, S. P., Matthijs, S., Wright, V. J., Fletcher, M. P., Chhabra, S. R., Lamont, I. L., Kong, X., Hider, R. C., Cornelis, P., Cámara, M., et al. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.11.014 · Cited by 498
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial
Rhoads, D. D., Wolcott, R. D., Kuskowski, M. A., Wolcott, B. M., Ward, L. S., & Sulakvelidze, A. (2009) · Journal of Wound Care · doi:10.12968/jowc.2009.18.6.42801 · Cited by 468
Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms.
Poole, K. (2001) · PubMed · Cited by 456
Messing with Bacterial Quorum Sensing
González, J. E., & Keshavan, N. D. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00002-06 · Cited by 425
Sharma, V. K., Siskova, K. M., Zboril, R., & Gardea-Torresdey, J. L. (2014) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2013.12.002 · Cited by 413
Contribution of Quorum Sensing to the Virulence of Pseudomonas aeruginosa in Burn Wound Infections
Rumbaugh, K. P., Griswold, J. A., Iglewski, B. H., & Hamood, A. N. (1999) · Infection and Immunity · doi:10.1128/iai.67.11.5854-5862.1999 · Cited by 408
Regulation of Pseudomonas Quinolone Signal Synthesis in Pseudomonas aeruginosa
Wade, D. S., Calfee, M. W., Rocha, E. R., Ling, E. A., Engstrom, E., Coleman, J. P., & Pesci, E. C. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.13.4372-4380.2005 · Cited by 387
Pseudomonas aeruginosa adapts its iron uptake strategies in function of the type of infections
Cornelis, P., & Dingemans, J. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00075 · Cited by 382
Fu, W., Forster, T., Mayer, O., Curtin, J. J., Lehman, S. M., & Donlan, R. M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00669-09 · Cited by 362
Suh, S.-J., Silo-Suh, L., Woods, D. E., Hassett, D. J., West, S. E. H., & Ohman, D. E. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.13.3890-3897.1999 · Cited by 356
Chemani, C., Imberty, A., de Bentzmann, S., Pierre, M., Wimmerová, M., Guery, B. P., & Faure, K. (2009) · Infection and Immunity · doi:10.1128/iai.01204-08 · Cited by 325
Pearson, J. P., Feldman, M., Iglewski, B. H., & Prince, A. (2000) · Infection and Immunity · doi:10.1128/iai.68.7.4331-4334.2000 · Cited by 323
Antibiotic Adjuvants: Diverse Strategies for Controlling Drug‐Resistant Pathogens
Gill, E. E., Franco, O. L., & Hancock, R. E. W. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12478 · Cited by 319
Bacteriophages Can Treat and Prevent Pseudomonas aeruginosa Lung Infections
Debarbieux, L., Leduc, D., Maura, D., Morello, E., Criscuolo, A., Grossi, O., Balloy, V., & Touqui, L. (2010) · The Journal of Infectious Diseases · doi:10.1086/651135 · Cited by 304
Valdéz, J. C., Peral, M. C., Rachid, M., Santana, M., & Perdigón, G. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01142.x · Cited by 301
Naqvi, S. Z., Kiran, U., Ali, Jamal, Hameed, Ahmed, & Ali (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s49284 · Cited by 299
The Use of Phages for the Removal of Infectious Biofilms
Azeredo, J., & Sutherland, I. (2008) · Current Pharmaceutical Biotechnology · doi:10.2174/138920108785161604 · Cited by 292
Lamers, R. P., Cavallari, J. F., & Burrows, L. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060666 · Cited by 291
Williamson, K. S., Richards, L. A., Perez-Osorio, A. C., Pitts, B., McInnerney, K., Stewart, P. S., & Franklin, M. J. (2012) · Journal of Bacteriology · doi:10.1128/jb.00022-12 · Cited by 289
ExoU is a potent intracellular phospholipase
Sato, H., & Frank, D. W. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04194.x · Cited by 287
ZnO nanoparticles inhibit Pseudomonas aeruginosa biofilm formation and virulence factor production
Lee, J.-H., Kim, Y.-G., Cho, M. H., & Lee, J. (2014) · Microbiological Research · doi:10.1016/j.micres.2014.05.005 · Cited by 276
Johansson, E. M. V., Crusz, S. A., Kolomiets, E., Buts, L., Kadam, R. U., Cacciarini, M., Bartels, K.-M., Diggle, S. P., Cámara, M., Williams, P., et al. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.10.009 · Cited by 263
The potential of desferrioxamine-gallium as an anti- Pseudomonas therapeutic agent
Banin, E., Lozinski, A., Brady, K. M., Berenshtein, E., Butterfield, P. W., Moshe, M., Chevion, M., Greenberg, E. P., & Banin, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808608105 · Cited by 258
McGrath, S., Wade, D. S., & Pesci, E. C. (2004) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00849-8 · Cited by 255
Studies of photokilling of bacteria using titanium dioxide nanoparticles
Tsuang, Y., Sun, J., Huang, Y., Lu, C., Chang, W. H., & Wang, C. (2008) · Artificial Organs · doi:10.1111/j.1525-1594.2007.00530.x · Cited by 247
Mishra, M., Byrd, M. S., Sergeant, S., Azad, A. K., Parsek, M. R., McPhail, L., Schlesinger, L. S., & Wozniak, D. J. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01704.x · Cited by 243
Jayaraman, P., Sakharkar, M. K., Lim, C. S., Tang, T. H., & Sakharkar, K. R. (2010) · International Journal of Biological Sciences · doi:10.7150/ijbs.6.556 · Cited by 242
Recent advances in the treatment of Pseudomonas aeruginosainfections in cystic fibrosis
Høiby, N. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-32 · Cited by 234
Phage Neutralization by Sera of Patients Receiving Phage Therapy
Łusiak-Szelachowska, M., Żaczek, M., Weber-Dąbrowska, B., Międzybrodzki, R., Kłak, M., Fortuna, W., Letkiewicz, S., Rogóż, P., Szufnarowski, K., Jończyk-Matysiak, E., et al. (2014) · Viral Immunology · doi:10.1089/vim.2013.0128 · Cited by 218
Jakobsen, T. H., Bragason, S. K., Phipps, R. K., Christensen, L. D., van Gennip, M., Alhede, M., Skindersoe, M., Larsen, T. O., Høiby, N., Bjarnsholt, T., et al. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.05992-11 · Cited by 213
Eugenol inhibits quorum sensing at sub-inhibitory concentrations
Zhou, L., Zheng, H., Tang, Y., Yu, W., & Gong, Q. (2013) · Biotechnology Letters · doi:10.1007/s10529-012-1126-x · Cited by 212
Moreau-Marquis, S., O'Toole, G. A., & Stanton, B. A. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0299oc · Cited by 204
Pseudomonas aeruginosa virulence and therapy: Evolving translational strategies*
Veesenmeyer, J. L., Hauser, A. R., Lisboa, T., & Rello, J. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819ff137 · Cited by 196
Therapy of Experimental Pseudomonas Infections with a Nonreplicating Genetically Modified Phage
Hagens, S., Habel, A., von Ahsen, U., von Gabain, A., & Bläsi, U. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3817-3822.2004 · Cited by 187
Döring, G., Meisner, C., Stern, M., & for the Flagella Vaccine Trial Study Group (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702403104 · Cited by 186
Reithofer, M. R., Lakshmanan, A., Ping, A. T. K., Chin, J. M., & Hauser, C. A. E. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.102 · Cited by 179
Forestier, C., Guelon, D., Cluytens, V., Gillart, T., Sirot, J., & De Champs, C. (2008) · Critical Care · doi:10.1186/cc6907 · Cited by 178
Krishnan, T., Yin, W.-F., & Chan, K.-G. (2012) · Sensors · doi:10.3390/s120404016 · Cited by 176
Quorum Sensing Inhibition Selects for Virulence and Cooperation in Pseudomonas aeruginosa
Köhler, T., Perron, G. G., Buckling, A., & van Delden, C. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000883 · Cited by 171
Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections
Rangel-Vega, A., Bernstein, L. R., Mandujano-Tinoco, E. A., GarcÃa-Contreras, S. J., & GarcÃa-Contreras, R. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00282 · Cited by 168
Torres-Barceló, C., Arias-Sánchez, F. I., Vasse, M., Ramsayer, J., Kaltz, O., & Hochberg, M. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106628 · Cited by 166
Scott, C., Abdelghany, Quinn, Ingram, Gilmore, Donnelly, & Taggart (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s34341 · Cited by 161
Johansen, H. K., Moskowitz, S. M., Ciofu, O., Pressler, T., & Høiby, N. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.02.003 · Cited by 161
Deslouches, B., Islam, K., Craigo, J. K., Paranjape, S. M., Montelaro, R. C., & Mietzner, T. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3208-3216.2005 · Cited by 159
Evaluation of Flagella and Flagellin of Pseudomonas aeruginosa as Vaccines
Campodónico, V. L., Llosa, N. J., Grout, M., Döring, G., Maira‐Litrán, T., & Pier, G. B. (2009) · Infection and Immunity · doi:10.1128/iai.00806-09 · Cited by 151
Sobieszczyk, M. E. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh369 · Cited by 147
Li, X.-Z., Barré, N., & Poole, K. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.6.885 · Cited by 146
Antivirulence activity of azithromycin in Pseudomonas aeruginosa
Imperi, F., Leoni, L., & Visca, P. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00178 · Cited by 144
Halwani, M., Yebio, B., Suntres, Z. E., Alipour, M., Azghani, A. O., & Omri, A. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn422 · Cited by 140
Carpenter, A. W., Worley, B. V., Slomberg, D. L., & Schoenfisch, M. H. (2012) · Biomacromolecules · doi:10.1021/bm301108x · Cited by 132
Antimicrobial Peptoids Are Effective against Pseudomonas aeruginosa Biofilms
Kapoor, R., Wadman, M. W., Dohm, M. T., Czyzewski, A. M., Spormann, A. M., & Barron, A. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01516-10 · Cited by 130
Gallium Maltolate Treatment Eradicates Pseudomonas aeruginosa Infection in Thermally Injured Mice
DeLeon, K., Balldin, F., Watters, C., Hamood, A. N., Griswold, J., Sreedharan, S. P., & Rumbaugh, K. P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01330-08 · Cited by 127
van Delden, C., Köhler, T., Brunner‐Ferber, F., François, B., Carlet, J. M., & Pechère, J.-C. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2559-3 · Cited by 122
Inhibitors and Specificity of Pseudomonas aeruginosa LasA
Kessler, E., Safrin, M., Abrams, W. R., Rosenbloom, J., & Ohman, D. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.9884 · Cited by 119
Miyairi, S., Tateda, K., Fuse, E. T., Ueda, C., Saito, H., Takabatake, T., Ishii, Y., Horikawa, M., Ishiguro, M., Standiford, T. J., et al. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46658-0 · Cited by 119
Actin cytoskeleton disruption by ExoY and its effects onPseudomonas aeruginosainvasion
Cowell, B. A., Evans, D. J., & Fleiszig, S. M. J. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.06.044 · Cited by 118
Heo, Y.-J., Lee, Y.-R., Jung, H.-H., Lee, J., Ko, G., & Cho, Y. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01646-08 · Cited by 116
Garbe, J., Wesche, A., Bunk, B., Kazmierczak, M., Selezska, K., Rohde, C., Sikorski, J., Rohde, M., Jahn, D., & Schobert, M. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-301 · Cited by 114
Cystic fibrosis microbiology: Advances in antimicrobial therapy
Waters, V. J., & Smyth, A. R. (2015) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2015.02.005 · Cited by 114
lasA and lasB genes of Pseudomonas aeruginosa: analysis of transcription and gene product activity
Toder, D. S., Ferrell, S. J., Nezezon, J., Rust, L., & Iglewski, B. H. (1994) · Infection and Immunity · doi:10.1128/iai.62.4.1320-1327.1994 · Cited by 113
Novel approaches to the treatment ofPseudomonas aeruginosainfections in cystic fibrosis
Hurley, M. N., Cámara, M., & Smyth, A. R. (2012) · European Respiratory Journal · doi:10.1183/09031936.00042012 · Cited by 112
Breaking a pathogen's iron will: Inhibiting siderophore production as an antimicrobial strategy
Lamb, A. L. (2015) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2015.05.001 · Cited by 111
Kwan, J. C., Meickle, T., Ladwa, D., Teplitski, M., Paul, V. J., & Luesch, H. (2011) · Molecular BioSystems · doi:10.1039/c0mb00180e · Cited by 110
Role of quorum sensing by Pseudomonas aeruginosa in microbial keratitis and cystic fibrosis
Willcox, M. D. P., Zhu, H., Conibear, T. C. R., Hume, E. B. H., Givskov, M., Kjelleberg, S. J., & Rice, S. A. (2008) · Microbiology · doi:10.1099/mic.0.2008/019281-0 · Cited by 109
Giacometti, A., Cirioni, O., Barchiesi, F., Fortuna, M., & Scalise, G. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.5.641 · Cited by 105
[Effect of silver nanoparticle dressing on second degree burn wound].
Chen, J., Han, C., Lin, X.-W., Tang, Z., & Su, S.-J. (2006) · PubMed · Cited by 102
Osmoprotectants and phosphate regulate expression of phospholipase C in Pseudomonas aeruginosa
Shoriridge, V. D., Lazdunski, A. M., & Vasil, M. L. (1992) · Molecular Microbiology · doi:10.1111/j.1365-2958.1992.tb01537.x · Cited by 99
Jyot, J., Balloy, V., Jouvion, G., Verma, A., Touqui, L., Huerre, M., Chignard, M., & Ramphal, R. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir045 · Cited by 99
Sajjan, U. S., Tran, L. T., Solé, N. A., Rovaldi, C., Akiyama, A., Friden, P. M., Forstner, J., & Rothstein, D. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3437-3444.2001 · Cited by 98
Anti-PcrV antibody strategies against virulentPseudomonas aeruginosa
Sawa, T., Ito, E., Nguyen, V. H., & Haight, M. J. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/21645515.2014.971641 · Cited by 95
Deguise, I., Lagnoux, D., & Roy, R. (2007) · New Journal of Chemistry · doi:10.1039/b701237c · Cited by 91
Kolomiets, E., Swiderska, M. A., Kadam, R. U., Johansson, E. M. V., Jaeger, K., Darbre, T., & Reymond, J. (2009) · ChemMedChem · doi:10.1002/cmdc.200800380 · Cited by 89
Expression ofPseudomonas aeruginosaToxin ExoS Effectively Induces Apoptosis in Host Cells
Jia, J., Wang, Y., Zhou, L. J., & Jin, S. (2006) · Infection and Immunity · doi:10.1128/iai.00591-06 · Cited by 81
Rolain, J., Hraiech, S., & Brégeon, F. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s53123 · Cited by 80
Antibacterial activity of some Indian ayurvedic preparations against enteric bacterial pathogens
Tambekar, D., & Dahikar, S. (2011) · Journal of Advanced Pharmaceutical Technology & Research · doi:10.4103/2231-4040.79801 · Cited by 78
Vaccination against respiratory Pseudomonas aeruginosa infection
Grimwood, K., Kyd, J. M., Owen, S., Massa, H. M., & Cripps, A. W. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.34296 · Cited by 78
Mansouri, E., Gabelsberger, J., Knapp, B., Hundt, E., Lenz, U., Hungerer, K., Gilleland, H. E., Staczek, J., Domdey, H., & Specht, B.-U. V. (1999) · Infection and Immunity · doi:10.1128/iai.67.3.1461-1470.1999 · Cited by 78
Screening of Lactobacillus spp. for the prevention of Pseudomonas aeruginosa pulmonary infections
Alexandre, Y., Berre, R. L., Barbier, G., & Blay, G. L. (2014) · BMC Microbiology · doi:10.1186/1471-2180-14-107 · Cited by 73
Dubois, V., Arpin, C., Melon, M., Melon, B., Andre, C., Frigo, C., & Quentin, C. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.6.2072-2078.2001 · Cited by 73
Morita, Y., Tomida, J., & Kawamura, Y. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00008 · Cited by 72
Mohamed, R. R., & Sabaa, M. W. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.05.025 · Cited by 71
Concentration of the antibacterial precursor thiocyanate in cystic fibrosis airway secretions
Lorentzen, D., Durairaj, L., Pezzulo, A. A., Nakano, Y., Launspach, J. L., Stoltz, D. A., Zamba, G., McCray, P. B., Zabner, J., Welsh, M. J., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.02.013 · Cited by 69
Deng, Y., Boon, C., Chen, S., Lim, A., & Zhang, L. (2013) · BMC Microbiology · doi:10.1186/1471-2180-13-231 · Cited by 62
Gallium induces the production of virulence factors inPseudomonas aeruginosa
García‐Contreras, R., Peréz-Eretza, B., Lira‐Silva, E., Jasso‐Chávez, R., Coria‐Jiménez, R., Rangel-Vega, A., Maeda, T., & Wood, T. K. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12105 · Cited by 61
Utilization of Colistin for Treatment of Multidrug‐Resistant Pseudomonas aeruginosa
Sabuda, D. M., Laupland, K. B., Pitout, J. D. D., Dalton, B., Rabin, H. R., Louie, T., & Conly, J. M. (2008) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2008/743197 · Cited by 60
Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection
Steinkamp, G., Schmitt‐Grohé, S., Döring, G., Staab, D., Pfründer, D., Beck, G., Schubert, R., & Zielen, S. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.03.009 · Cited by 59
Varma, P., Nisha, N., Dinesh, K. R., Kumar, A., & Biswas, R. (2011) · Microbial Physiology · doi:10.1159/000328512 · Cited by 58
Self-citationMoreau‐Marquis, S., Coutermarsh, B., & Stanton, B. A. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku357 · Cited by 55
Loo, C., Young, P. M., Lee, W., Cavaliere, R., Whitchurch, C. B., & Rohanizadeh, R. (2014) · Biofouling · doi:10.1080/08927014.2014.926475 · Cited by 54
Galle, M., Jin, S., Bogaert, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041547 · Cited by 48
Baumann, U., Göcke, K., Gewecke, B., Freihorst, J., & von Specht, B. U. (2007) · Respiratory Research · doi:10.1186/1465-9921-8-57 · Cited by 45
Göcke, K., Baumann, U., Hagemann, H., Gabelsberger, J., Hahn, H., Freihorst, J., & von Specht, B. U. (2003) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(03)00094-4 · Cited by 41
Kandasamy, S., Khan, W., Evans, F., Critchley, A. T., & Prithiviraj, B. (2012) · Marine Drugs · doi:10.3390/md10010084 · Cited by 40
Jiang, M., Yao, J., & Feng, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096609 · Cited by 38
Nguyen, D. M., Emond, M. J., Mayer-Hamblett, N., Saiman, L. M., Marshall, B. C., & Burns, J. L. (2007) · Pediatric Pulmonology · doi:10.1002/ppul.20620 · Cited by 36
Jarosz, L. M., Ovchinnikova, E. S., Meijler, M. M., & Krom, B. P. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002312 · Cited by 31
Effect of novel antibacterial gallium-carboxymethyl cellulose on Pseudomonas aeruginosa
Valappil, S. P., Yiu, H. H. P., Bouffier, L., Hope, C. K., Evans, G., Claridge, J. B., Higham, S. M., & Rosseinsky, M. J. (2012) · Dalton Transactions · doi:10.1039/c2dt32235h · Cited by 31
Grande, K. K., Gustin, J. K., Kessler, E., & Ohman, D. E. (2007) · Journal of Bacteriology · doi:10.1128/jb.01828-06 · Cited by 30
Stuart, R. K., & Pollack, M. (1982) · Infection and Immunity · doi:10.1128/iai.38.1.206-211.1982 · Cited by 22
Immunological evaluation of OMP-F of native Iranian Pseudomonas aeruginosa as a protective vaccine
Ahmadi, H., Tabaraie, B., Maleknia, S., Pormirzagholi, F., Nejati, M., & ., M. H. H. (2012) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.2220 · Cited by 6
Cited by
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00539 · Cited by 1,644
Shannon, E., & Abu-Ghannam, N. (2016) · Marine Drugs · doi:10.3390/md14040081 · Cited by 385
Borges, A., Abreu, A., Dias, C., Saavedra, M., Borges, F., & Simões, M. (2016) · Molecules · doi:10.3390/molecules21070877 · Cited by 308
Mutuku, C., Gazdag, Z., & Melegh, S. (2022) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-022-03334-0 · Cited by 280
Metadata
- Authors
- Chatterjee, M., Anju, C. P., Biswas, L., Anil Kumar, V., Gopi Mohan, C., & Biswas, R.
- Venue
- International Journal of Medical Microbiology
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 306
- Issue
- 1
- Pages
- 48-58
- ISSN
- 1438-4221 (ISSN-L)
- OpenAlex
- W2175809912
- Cited by
- 312
- References
- 125
- FWCI
- 7.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.